UCSF-Kaiser Urological Epidemiology Research Career Development Program

项目概要： 概况. UCSF-Kaiser Permanente泌尿流行病学研究职业发展 计划（UCSF-KPNC UroEpi）将为初级研究人员提供实用的跨学科培训， 成为非恶性泌尿流行病学独立研究者的途径。大学 加州、弗朗西斯科（UCSF）和北方加州凯撒医疗机构（KPNC）将合作， 为初级学院级调查员提供长期成功所需的指导、技能和经验。 学者将被安置在UCSF和KPNC研究部（DOR），这两个部门都拥有强大的科学研究能力。 基础设施，他们将能够访问无与伦比的数据资源集，包括整个 KPNC患者人群和广泛的前瞻性队列。合作的历史， 这两个机构将使导师和学者能够随时进行交流、会面和分享 资源，并继续发展有前途的年轻研究人员成为独立的卓越记录 investigators. 培训计划和候选人管道。UCSF-KPNC UroEpi学者计划高度 结构化，包括全面的指导，正式的教学计划和动手研究。 每位学者都将拥有一个多学科的导师团队，并可以接触到广泛的科学家网络。 临床和运营领导者教学计划包括证书，硕士或博士学位 研究方法和/或流行病学计划，并指导研讨会系列与正在进行的工作 和研究技能课程。我们已经确定了良性泌尿外科的13个研究项目领域， 利用UCSF-KPNC环境的多样性，直接访问现实生活中的临床医生和患者， 导师的方法和内容领域的优势。在这个结构中，学者们将开发一个投资组合 研究项目和技能，以指导他们过渡到独立的调查。我们有一个 优秀的管道不同的学者候选人和强大的抵押资源。 创新与影响。该计划的创新配对的顶级学术中心与学习 和综合医疗保健系统将是NIDDK资源的一个很好的投资， 泌尿流行病学研究在一个独特的肥沃环境中的增长。嵌入式初级 研究人员在这些设置是一种自然的方式，最大限度地提高患者和临床医生对他们的影响， 研究选择。这种创造性的配置将优化该计划工作的下游影响 现实生活中的流行病学和以病人为中心的结果。我们有着悠久的合作历史， 多学科研究，将补充和增强NIDDK支持的其他大型项目， 例如奥布莱恩、MAPP和LURN中心。因此，环境使UroEpi学者能够工作 与有成就的研究人员和导师密切合作，以促进研究问题的优先次序， 重要的病人和丰富的解释研究结果的实践和病人的健康。

PROJECT SUMMARY: Overview. The UCSF-Kaiser Permanente Urological Epidemiology Research Career Development Program (UCSF-KPNC UroEpi) will provide practical, interdisciplinary training to junior researchers en route to becoming independent investigators in non-malignant urological epidemiology. The University of California, San Francisco (UCSF) and Kaiser Permanente Northern California (KPNC) will collaborate to give junior faculty-level investigators the mentoring, skills, and experience they need for long-term success. Scholars will be housed at UCSF and the KPNC Division of Research (DOR), both with robust scientific infrastructures, where they will be able to access an unparalleled set of data resources, including the entire KPNC patient population, and a wide range of prospective cohorts. The history of collaboration between the two institutions will enable the mentors and Scholars to readily communicate, meet, and share resources and continue a superb track record of developing promising young researchers into independent investigators. Training Program and Candidate Pipeline. The program for UCSF-KPNC UroEpi Scholars is highly structured and includes comprehensive mentoring, a formal didactic program, and hands on research. Each scholar will have a multidisciplinary mentor team as well as access to extensive networks of scientists and clinical and operational leaders. The didactic program includes a certificate, masters or PhD degree program in research methods and/or epidemiology, and mentored seminar series with work-in-progress and research skills sessions. We have identified 13 Research Program Areas in benign urology that leverage the UCSF-KPNC environments’ diversity, direct access to real-life clinicians and patients, and the mentor’s methodological and content area strengths. Within this structure, scholars will develop a portfolio of research projects and skills to guide their transition to independence as investigators. We have an excellent pipeline of diverse scholar candidates and robust collateral resources. Innovation and Impact. This program’s innovative pairing of a top tier academic center with a learning and integrated health care system will be an excellent investment of NIDDK resources that will catalyze growth of urological epidemiology research in a uniquely fertile environment. Embedding junior researchers in these settings is a natural way of maximizing the influence of patients and clinicians on their research choices. This creative configuration will optimize the downstream impact of this program’s work on real-life epidemiology and patient-centered outcomes. We have a long history of collaborative, multidisciplinary research that will complement and augment other large projects supported by NIDDK, such as O’Brien, MAPP, and LURN Centers. Thus, the environment enables the UroEpi Scholars to work closely with accomplished researchers and mentors to facilitate the prioritization of research questions that matter to patients and to enrich interpretation of research findings for practice and patient health.